You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

ACCORD HLTHCARE Company Profile


✉ Email this page to a colleague

« Back to Dashboard


What is the competitive landscape for ACCORD HLTHCARE, and what generic and branded alternatives to ACCORD HLTHCARE drugs are available?

ACCORD HLTHCARE has one hundred and fifty-four approved drugs.

There are three tentative approvals on ACCORD HLTHCARE drugs.

Summary for ACCORD HLTHCARE
US Patents:0
Tradenames:131
Ingredients:128
NDAs:154

Drugs and US Patents for ACCORD HLTHCARE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Accord Hlthcare ARIPIPRAZOLE aripiprazole TABLET;ORAL 206251-002 Dec 7, 2016 AB RX No No ⤷  Sign Up ⤷  Sign Up
Accord Hlthcare BICALUTAMIDE bicalutamide TABLET;ORAL 078917-001 Jul 6, 2009 AB RX No No ⤷  Sign Up ⤷  Sign Up
Accord Hlthcare CLOBAZAM clobazam TABLET;ORAL 212398-002 May 23, 2019 DISCN No No ⤷  Sign Up ⤷  Sign Up
Accord Hlthcare AMLODIPINE BESYLATE amlodipine besylate TABLET;ORAL 202553-002 Apr 29, 2013 AB RX No No ⤷  Sign Up ⤷  Sign Up
Accord Hlthcare SOLIFENACIN SUCCINATE solifenacin succinate TABLET;ORAL 207477-001 Jan 4, 2022 DISCN No No ⤷  Sign Up ⤷  Sign Up
Accord Hlthcare DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate TABLET;ORAL 214347-006 Nov 22, 2021 DISCN No No ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Paragraph IV (Patent) Challenges for ACCORD HLTHCARE drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe for Injection 100 mcg/vial and 500 mcg/vial ➤ Subscribe 2015-04-14
➤ Subscribe for Injection 200 mcg/vial ➤ Subscribe 2015-05-01
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.